tiprankstipranks
Trending News
More News >
Shanrong Biotechnology Corp (SRBT)
OTHER OTC:SRBT
US Market

Shanrong Biotechnology (SRBT) Income Statement

Compare
5 Followers

Shanrong Biotechnology Income Statement

Last quarter (Q3 2023), Shanrong Biotechnology's total revenue was $0.00, a decrease of ― from previous quarter. In Q3, Shanrong Biotechnology's net income was $-8.75K. See Shanrong Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 17
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 78.98K$ 31.75K
Depreciation and Amortization
$ 228.49K$ 52.52K
EBITDA
$ -78.99K$ -31.75K
Operating Income
$ -78.99K$ -31.75K
Other Income/Expenses
$ 7.00$ -3.00
Pretax Income
$ -78.98K$ -31.75K
Net Income
$ -78.98K$ -31.75K
Per Share Metrics
Basic EPS
$ -0.16$ -0.07
Diluted EPS
$ -0.16$ -0.07
Weighted Average Shares Outstanding
484.85K 484.85K
Weighted Average Shares Outstanding (Diluted)
484.85K 484.85K
Currency in USD

Shanrong Biotechnology Earnings and Revenue History